Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thyroid Neoplasms | 81 | 2024 | 2326 | 9.400 |
Why?
|
Adenocarcinoma, Follicular | 18 | 2024 | 323 | 4.320 |
Why?
|
Salivary Gland Neoplasms | 16 | 2022 | 304 | 3.530 |
Why?
|
Thyroid Nodule | 16 | 2024 | 760 | 3.420 |
Why?
|
Carcinoma, Papillary | 23 | 2022 | 784 | 2.420 |
Why?
|
Carcinoma, Neuroendocrine | 7 | 2022 | 338 | 2.200 |
Why?
|
Proto-Oncogene Proteins c-ret | 8 | 2021 | 225 | 1.980 |
Why?
|
Thyroid Gland | 22 | 2023 | 1167 | 1.970 |
Why?
|
Carcinoma | 19 | 2021 | 2330 | 1.890 |
Why?
|
Gene Rearrangement | 7 | 2021 | 1125 | 1.870 |
Why?
|
Proto-Oncogene Proteins B-raf | 25 | 2023 | 2052 | 1.810 |
Why?
|
Maxillary Sinus Neoplasms | 4 | 2022 | 39 | 1.730 |
Why?
|
Adenoma, Oxyphilic | 5 | 2024 | 147 | 1.680 |
Why?
|
Biopsy, Fine-Needle | 19 | 2022 | 1110 | 1.560 |
Why?
|
Parathyroid Glands | 3 | 2022 | 517 | 1.480 |
Why?
|
Gene Fusion | 6 | 2023 | 354 | 1.450 |
Why?
|
Receptor, trkA | 4 | 2023 | 159 | 1.420 |
Why?
|
Larynx | 3 | 2024 | 492 | 1.380 |
Why?
|
Adrenal Gland Neoplasms | 5 | 2020 | 732 | 1.360 |
Why?
|
Parathyroid Neoplasms | 2 | 2022 | 241 | 1.350 |
Why?
|
Thyroidectomy | 21 | 2024 | 902 | 1.330 |
Why?
|
Carcinoma, Papillary, Follicular | 5 | 2018 | 60 | 1.280 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2024 | 1594 | 1.270 |
Why?
|
Pheochromocytoma | 4 | 2020 | 328 | 1.270 |
Why?
|
Immunohistochemistry | 30 | 2024 | 11065 | 1.210 |
Why?
|
Carcinoma, Medullary | 4 | 2021 | 115 | 1.160 |
Why?
|
Oxyphil Cells | 5 | 2023 | 56 | 1.160 |
Why?
|
Bronchial Neoplasms | 2 | 2023 | 110 | 1.020 |
Why?
|
Mutation | 39 | 2024 | 29928 | 0.990 |
Why?
|
Paraganglioma | 4 | 2020 | 142 | 0.980 |
Why?
|
Head and Neck Neoplasms | 15 | 2023 | 2882 | 0.970 |
Why?
|
Hypokalemic Periodic Paralysis | 1 | 2024 | 7 | 0.950 |
Why?
|
Paranasal Sinus Neoplasms | 4 | 2023 | 240 | 0.940 |
Why?
|
Nasopharyngeal Neoplasms | 3 | 2023 | 287 | 0.910 |
Why?
|
Thyrotoxicosis | 1 | 2024 | 85 | 0.880 |
Why?
|
Tongue Neoplasms | 5 | 2024 | 183 | 0.880 |
Why?
|
Laryngeal Edema | 1 | 2023 | 21 | 0.850 |
Why?
|
Laryngeal Neoplasms | 2 | 2024 | 514 | 0.840 |
Why?
|
Papilloma | 1 | 2023 | 141 | 0.820 |
Why?
|
Carcinoma, Mucoepidermoid | 3 | 2022 | 89 | 0.820 |
Why?
|
Diagnosis, Differential | 32 | 2024 | 12950 | 0.800 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 4 | 2022 | 936 | 0.790 |
Why?
|
Receptors, Thyroid Hormone | 7 | 2022 | 199 | 0.780 |
Why?
|
GTP Phosphohydrolases | 2 | 2024 | 516 | 0.770 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 2 | 2021 | 40 | 0.770 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2022 | 487 | 0.760 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2021 | 311 | 0.750 |
Why?
|
Succinate Dehydrogenase | 2 | 2019 | 145 | 0.740 |
Why?
|
Muscle Weakness | 1 | 2024 | 413 | 0.740 |
Why?
|
Carcinoma, Acinar Cell | 2 | 2022 | 62 | 0.740 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2021 | 61 | 0.730 |
Why?
|
Receptor, trkC | 1 | 2020 | 63 | 0.730 |
Why?
|
Receptors, Somatostatin | 1 | 2021 | 136 | 0.720 |
Why?
|
Papillomavirus Infections | 10 | 2023 | 1611 | 0.700 |
Why?
|
Adrenal Rest Tumor | 2 | 2017 | 5 | 0.670 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2022 | 161 | 0.670 |
Why?
|
Laryngeal Diseases | 3 | 2024 | 243 | 0.640 |
Why?
|
Humans | 207 | 2024 | 757650 | 0.620 |
Why?
|
Neck | 2 | 2021 | 731 | 0.610 |
Why?
|
Carcinoma, Squamous Cell | 12 | 2023 | 4021 | 0.610 |
Why?
|
Hyperparathyroidism | 1 | 2019 | 337 | 0.600 |
Why?
|
Graves Disease | 2 | 2021 | 238 | 0.600 |
Why?
|
Oropharyngeal Neoplasms | 5 | 2022 | 491 | 0.600 |
Why?
|
Angiomyolipoma | 3 | 2020 | 184 | 0.600 |
Why?
|
Pharyngeal Diseases | 2 | 2019 | 134 | 0.590 |
Why?
|
Adenoma | 5 | 2021 | 2147 | 0.590 |
Why?
|
Hemangiopericytoma | 2 | 2015 | 71 | 0.580 |
Why?
|
Indoles | 7 | 2015 | 1825 | 0.570 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2021 | 608 | 0.570 |
Why?
|
Cytodiagnosis | 2 | 2020 | 441 | 0.570 |
Why?
|
Adrenocortical Carcinoma | 2 | 2017 | 88 | 0.560 |
Why?
|
Pericytes | 3 | 2023 | 293 | 0.560 |
Why?
|
Iodine Radioisotopes | 7 | 2024 | 1032 | 0.540 |
Why?
|
Hemangiosarcoma | 2 | 2015 | 216 | 0.510 |
Why?
|
Middle Aged | 87 | 2024 | 219219 | 0.510 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2017 | 161 | 0.510 |
Why?
|
Carcinoma, Ductal | 4 | 2022 | 97 | 0.510 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2017 | 217 | 0.500 |
Why?
|
Hemangioendothelioma | 1 | 2015 | 111 | 0.490 |
Why?
|
Ear Neoplasms | 1 | 2015 | 118 | 0.490 |
Why?
|
Dermoid Cyst | 2 | 2013 | 92 | 0.490 |
Why?
|
Epigenomics | 1 | 2021 | 936 | 0.490 |
Why?
|
Thyroid Hormone Receptors alpha | 3 | 2003 | 13 | 0.490 |
Why?
|
Ear Canal | 1 | 2015 | 146 | 0.480 |
Why?
|
Histoplasma | 1 | 2014 | 39 | 0.480 |
Why?
|
Oncogene Proteins | 1 | 2019 | 719 | 0.480 |
Why?
|
Aged | 71 | 2024 | 167889 | 0.470 |
Why?
|
Tuberous Sclerosis | 4 | 2020 | 1030 | 0.470 |
Why?
|
Sulfonamides | 6 | 2015 | 1972 | 0.470 |
Why?
|
Histoplasmosis | 1 | 2014 | 63 | 0.470 |
Why?
|
Carcinoma, Renal Cell | 7 | 2022 | 3153 | 0.470 |
Why?
|
Kidney Neoplasms | 9 | 2022 | 4221 | 0.460 |
Why?
|
Genes, p53 | 2 | 2015 | 712 | 0.460 |
Why?
|
Neoplasms, Multiple Primary | 3 | 2016 | 586 | 0.460 |
Why?
|
Palatine Tonsil | 1 | 2014 | 193 | 0.460 |
Why?
|
Female | 108 | 2024 | 389985 | 0.450 |
Why?
|
Male | 108 | 2024 | 358227 | 0.450 |
Why?
|
Frameshift Mutation | 1 | 2015 | 388 | 0.450 |
Why?
|
Ultrasonography | 9 | 2023 | 5951 | 0.440 |
Why?
|
Thyroid Hormones | 5 | 2003 | 403 | 0.440 |
Why?
|
DNA Helicases | 1 | 2019 | 853 | 0.440 |
Why?
|
Protein Kinases | 1 | 2020 | 1610 | 0.430 |
Why?
|
Cholesteatoma | 1 | 2013 | 28 | 0.430 |
Why?
|
Aged, 80 and over | 41 | 2024 | 58559 | 0.430 |
Why?
|
Transcription Factors | 10 | 2022 | 12092 | 0.430 |
Why?
|
Catecholamines | 3 | 2010 | 385 | 0.430 |
Why?
|
Adult | 71 | 2024 | 219747 | 0.430 |
Why?
|
Mutagenesis, Insertional | 1 | 2015 | 656 | 0.420 |
Why?
|
DNA Mutational Analysis | 10 | 2021 | 4107 | 0.410 |
Why?
|
Repressor Proteins | 3 | 2021 | 2976 | 0.400 |
Why?
|
Neoplasm Recurrence, Local | 11 | 2023 | 9245 | 0.380 |
Why?
|
PTEN Phosphohydrolase | 3 | 2017 | 1114 | 0.380 |
Why?
|
Tongue | 4 | 2023 | 403 | 0.380 |
Why?
|
Sinusitis | 5 | 2022 | 990 | 0.360 |
Why?
|
Goiter | 1 | 2010 | 87 | 0.360 |
Why?
|
Otitis Media | 1 | 2013 | 285 | 0.360 |
Why?
|
Parietal Lobe | 1 | 2015 | 849 | 0.360 |
Why?
|
Parathyroidectomy | 2 | 2022 | 241 | 0.350 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2015 | 989 | 0.350 |
Why?
|
Ganglioneuroma | 1 | 2010 | 53 | 0.350 |
Why?
|
Adenocarcinoma, Papillary | 1 | 2010 | 84 | 0.350 |
Why?
|
Papillomaviridae | 7 | 2023 | 1121 | 0.350 |
Why?
|
Young Adult | 33 | 2024 | 58764 | 0.350 |
Why?
|
Biopsy | 11 | 2021 | 6758 | 0.340 |
Why?
|
Diarrhea, Infantile | 1 | 2010 | 101 | 0.340 |
Why?
|
Retrospective Studies | 32 | 2024 | 79982 | 0.340 |
Why?
|
Rhinitis | 4 | 2022 | 746 | 0.330 |
Why?
|
Genomics | 4 | 2023 | 5788 | 0.330 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2015 | 2913 | 0.320 |
Why?
|
Hashimoto Disease | 1 | 2010 | 105 | 0.320 |
Why?
|
Thyroid Diseases | 3 | 2021 | 386 | 0.320 |
Why?
|
Membrane Proteins | 3 | 2024 | 7841 | 0.310 |
Why?
|
Temporal Bone | 1 | 2013 | 683 | 0.300 |
Why?
|
Endocrine Gland Neoplasms | 1 | 2008 | 23 | 0.300 |
Why?
|
Tonsillectomy | 1 | 2011 | 268 | 0.300 |
Why?
|
Antineoplastic Agents | 8 | 2022 | 13603 | 0.300 |
Why?
|
Spinal Cord Neoplasms | 1 | 2010 | 262 | 0.300 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2024 | 1727 | 0.290 |
Why?
|
Stathmin | 1 | 2008 | 70 | 0.290 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 2023 | 490 | 0.290 |
Why?
|
Adrenal Glands | 1 | 2010 | 553 | 0.290 |
Why?
|
Neoplasm Proteins | 2 | 2019 | 3608 | 0.290 |
Why?
|
Standard of Care | 1 | 2011 | 550 | 0.280 |
Why?
|
Nasal Mucosa | 3 | 2016 | 412 | 0.280 |
Why?
|
Parathyroid Hormone | 2 | 2022 | 1797 | 0.260 |
Why?
|
Triiodothyronine | 7 | 2005 | 493 | 0.250 |
Why?
|
Nuclear Proteins | 2 | 2022 | 5786 | 0.250 |
Why?
|
Paranasal Sinuses | 3 | 2019 | 265 | 0.240 |
Why?
|
Molecular Targeted Therapy | 3 | 2021 | 2796 | 0.240 |
Why?
|
Thyrotropin | 9 | 2014 | 832 | 0.240 |
Why?
|
Angiogenesis Inhibitors | 2 | 2014 | 2047 | 0.240 |
Why?
|
Thyroid Hormone Receptors beta | 5 | 2005 | 21 | 0.240 |
Why?
|
Adolescent | 23 | 2024 | 87832 | 0.230 |
Why?
|
Genetic Predisposition to Disease | 4 | 2020 | 17767 | 0.230 |
Why?
|
Prognosis | 12 | 2023 | 29493 | 0.230 |
Why?
|
RNA-Binding Protein FUS | 1 | 2024 | 75 | 0.230 |
Why?
|
Pathology, Clinical | 2 | 2020 | 375 | 0.230 |
Why?
|
In Situ Hybridization, Fluorescence | 6 | 2021 | 2506 | 0.230 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2020 | 610 | 0.220 |
Why?
|
Chronic Disease | 9 | 2022 | 9265 | 0.220 |
Why?
|
Chemokine CXCL9 | 1 | 2023 | 135 | 0.220 |
Why?
|
Algorithms | 2 | 2021 | 13952 | 0.220 |
Why?
|
Plasmacytoma | 1 | 2024 | 171 | 0.220 |
Why?
|
Hypokalemia | 1 | 2024 | 152 | 0.210 |
Why?
|
Tremor | 1 | 2024 | 191 | 0.210 |
Why?
|
Oncogene Fusion | 3 | 2021 | 81 | 0.210 |
Why?
|
Carcinoma, Adenoid Cystic | 2 | 2016 | 262 | 0.210 |
Why?
|
Salivary Cystatins | 1 | 2022 | 11 | 0.210 |
Why?
|
Seminoma | 1 | 2023 | 134 | 0.200 |
Why?
|
Cell Nucleus | 4 | 2017 | 2905 | 0.200 |
Why?
|
Indocyanine Green | 1 | 2023 | 235 | 0.200 |
Why?
|
Testicular Neoplasms | 2 | 2023 | 794 | 0.190 |
Why?
|
Salivary Glands, Minor | 1 | 2021 | 25 | 0.190 |
Why?
|
Nose Neoplasms | 2 | 2015 | 249 | 0.190 |
Why?
|
Osteopontin | 1 | 2023 | 301 | 0.190 |
Why?
|
Myoepithelioma | 1 | 2021 | 26 | 0.190 |
Why?
|
Nuclear Receptor Coactivator 1 | 5 | 2003 | 42 | 0.190 |
Why?
|
Kidney | 4 | 2021 | 7013 | 0.190 |
Why?
|
Receptors, Steroid | 1 | 2022 | 156 | 0.190 |
Why?
|
Neovascularization, Pathologic | 4 | 2015 | 2638 | 0.190 |
Why?
|
Predictive Value of Tests | 8 | 2021 | 15209 | 0.190 |
Why?
|
Calcitonin | 2 | 2013 | 330 | 0.190 |
Why?
|
Genome, Mitochondrial | 1 | 2021 | 66 | 0.190 |
Why?
|
Arm | 1 | 2024 | 583 | 0.180 |
Why?
|
Pituitary Gland | 2 | 2003 | 637 | 0.180 |
Why?
|
Eosinophilic Granuloma | 1 | 2020 | 27 | 0.180 |
Why?
|
Pathology, Molecular | 1 | 2023 | 327 | 0.170 |
Why?
|
Orchiectomy | 1 | 2022 | 463 | 0.170 |
Why?
|
Cell Polarity | 1 | 2023 | 637 | 0.170 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2022 | 194 | 0.170 |
Why?
|
Psychotic Disorders | 1 | 2015 | 3197 | 0.170 |
Why?
|
Vocal Cords | 2 | 2015 | 522 | 0.170 |
Why?
|
Collagenases | 5 | 2004 | 221 | 0.170 |
Why?
|
Gene Expression Profiling | 6 | 2022 | 9404 | 0.170 |
Why?
|
Sialometaplasia, Necrotizing | 1 | 2019 | 6 | 0.170 |
Why?
|
Thyroid Hormone Resistance Syndrome | 3 | 2005 | 15 | 0.160 |
Why?
|
Surgical Sponges | 1 | 2019 | 39 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2022 | 218 | 0.160 |
Why?
|
Neoplasm Staging | 7 | 2021 | 11083 | 0.160 |
Why?
|
Leg | 1 | 2024 | 1087 | 0.160 |
Why?
|
RNA, Neoplasm | 2 | 2019 | 749 | 0.160 |
Why?
|
Salivary Glands | 4 | 2022 | 229 | 0.160 |
Why?
|
Histone Acetyltransferases | 5 | 2003 | 337 | 0.160 |
Why?
|
Edema | 1 | 2023 | 769 | 0.160 |
Why?
|
Sequence Analysis | 1 | 2019 | 240 | 0.160 |
Why?
|
In Situ Hybridization | 3 | 2017 | 1900 | 0.150 |
Why?
|
Ribonuclease, Pancreatic | 2 | 2009 | 149 | 0.150 |
Why?
|
Laryngostenosis | 1 | 2020 | 167 | 0.150 |
Why?
|
Tracheal Stenosis | 1 | 2020 | 226 | 0.150 |
Why?
|
Translocation, Genetic | 3 | 2022 | 1387 | 0.150 |
Why?
|
RNA, Ribosomal | 2 | 2009 | 226 | 0.150 |
Why?
|
Neoplasm Invasiveness | 8 | 2020 | 3595 | 0.150 |
Why?
|
Bipolar Disorder | 1 | 2015 | 5083 | 0.150 |
Why?
|
Recurrent Laryngeal Nerve | 1 | 2019 | 143 | 0.150 |
Why?
|
Genes, ras | 2 | 2017 | 654 | 0.150 |
Why?
|
Keratin-14 | 2 | 2015 | 56 | 0.140 |
Why?
|
Sequence Analysis, RNA | 2 | 2022 | 2001 | 0.140 |
Why?
|
DNA, Mitochondrial | 2 | 2023 | 856 | 0.140 |
Why?
|
Ultrasonography, Prenatal | 2 | 2021 | 1744 | 0.140 |
Why?
|
Amyloidosis | 1 | 2024 | 817 | 0.140 |
Why?
|
Radiation Oncology | 1 | 2023 | 559 | 0.140 |
Why?
|
Tracheostomy | 1 | 2021 | 425 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 9 | 2024 | 36271 | 0.140 |
Why?
|
Cushing Syndrome | 2 | 2008 | 241 | 0.140 |
Why?
|
DNA, Viral | 3 | 2023 | 2194 | 0.140 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3839 | 0.140 |
Why?
|
Nasal Polyps | 1 | 2022 | 395 | 0.140 |
Why?
|
Phosphatidylcholines | 1 | 2018 | 405 | 0.140 |
Why?
|
Human papillomavirus 16 | 2 | 2016 | 266 | 0.140 |
Why?
|
Genotype | 9 | 2016 | 12951 | 0.140 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2018 | 203 | 0.130 |
Why?
|
Databases, Factual | 3 | 2021 | 7926 | 0.130 |
Why?
|
Protein Kinase Inhibitors | 7 | 2023 | 5639 | 0.130 |
Why?
|
Monitoring, Intraoperative | 1 | 2022 | 939 | 0.130 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2021 | 3613 | 0.130 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 316 | 0.130 |
Why?
|
Cell Proliferation | 9 | 2020 | 10416 | 0.130 |
Why?
|
Thoracic Neoplasms | 1 | 2018 | 265 | 0.130 |
Why?
|
Herpesvirus 4, Human | 1 | 2021 | 1075 | 0.130 |
Why?
|
Tonsillar Neoplasms | 1 | 2016 | 50 | 0.130 |
Why?
|
Laryngeal Mucosa | 1 | 2015 | 31 | 0.130 |
Why?
|
Methimazole | 1 | 2015 | 41 | 0.130 |
Why?
|
Genes, p16 | 1 | 2015 | 159 | 0.130 |
Why?
|
Conjunctival Neoplasms | 1 | 2016 | 77 | 0.120 |
Why?
|
Nasolacrimal Duct | 1 | 2016 | 79 | 0.120 |
Why?
|
Antithyroid Agents | 1 | 2015 | 72 | 0.120 |
Why?
|
Angiogenic Proteins | 1 | 2015 | 101 | 0.120 |
Why?
|
Lymphatic Metastasis | 6 | 2024 | 2915 | 0.120 |
Why?
|
Nuclear Receptor Coactivator 2 | 3 | 2003 | 40 | 0.120 |
Why?
|
Phenotype | 7 | 2020 | 16533 | 0.120 |
Why?
|
Neoplasm Metastasis | 4 | 2020 | 4888 | 0.120 |
Why?
|
Parotid Neoplasms | 1 | 2016 | 157 | 0.120 |
Why?
|
Foreign Bodies | 1 | 2019 | 397 | 0.120 |
Why?
|
Thyroid Function Tests | 4 | 2022 | 289 | 0.120 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2024 | 5254 | 0.120 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2018 | 607 | 0.120 |
Why?
|
Neoplasms | 5 | 2023 | 21990 | 0.120 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2024 | 1079 | 0.120 |
Why?
|
Adrenal Gland Diseases | 1 | 2015 | 141 | 0.120 |
Why?
|
Myofibroma | 1 | 2014 | 45 | 0.120 |
Why?
|
Biological Products | 1 | 2023 | 905 | 0.120 |
Why?
|
Brain Neoplasms | 1 | 2015 | 8981 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 4567 | 0.120 |
Why?
|
Telepathology | 1 | 2014 | 77 | 0.120 |
Why?
|
Mandibular Neoplasms | 1 | 2015 | 130 | 0.120 |
Why?
|
Genes, myb | 1 | 2013 | 18 | 0.120 |
Why?
|
Eye Infections, Fungal | 1 | 2015 | 100 | 0.120 |
Why?
|
Mucormycosis | 1 | 2015 | 103 | 0.120 |
Why?
|
Carcinoma, Basosquamous | 1 | 2013 | 7 | 0.120 |
Why?
|
Animals | 33 | 2023 | 167777 | 0.120 |
Why?
|
Weight Loss | 2 | 2024 | 2671 | 0.110 |
Why?
|
Spinal Neoplasms | 1 | 2020 | 714 | 0.110 |
Why?
|
Imidazoles | 1 | 2020 | 1179 | 0.110 |
Why?
|
Mice | 24 | 2023 | 81107 | 0.110 |
Why?
|
Neoplasms, Second Primary | 1 | 2022 | 1051 | 0.110 |
Why?
|
Affective Disorders, Psychotic | 1 | 2015 | 186 | 0.110 |
Why?
|
Aphasia | 1 | 2015 | 192 | 0.110 |
Why?
|
Keratin-17 | 1 | 2013 | 26 | 0.110 |
Why?
|
Cell Line, Tumor | 10 | 2018 | 16891 | 0.110 |
Why?
|
Adenocarcinoma | 2 | 2022 | 6325 | 0.110 |
Why?
|
Oropharynx | 1 | 2014 | 133 | 0.110 |
Why?
|
Language | 1 | 2023 | 1529 | 0.110 |
Why?
|
Cachexia | 1 | 2015 | 197 | 0.110 |
Why?
|
Paraganglioma, Extra-Adrenal | 1 | 2013 | 45 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2018 | 3575 | 0.110 |
Why?
|
Penile Neoplasms | 1 | 2015 | 161 | 0.110 |
Why?
|
Chondrocalcinosis | 1 | 2015 | 82 | 0.110 |
Why?
|
Carcinoma, Endometrioid | 1 | 2016 | 276 | 0.110 |
Why?
|
Adrenalectomy | 1 | 2015 | 347 | 0.110 |
Why?
|
Nuclear Receptor Coactivator 3 | 2 | 2003 | 46 | 0.110 |
Why?
|
Lymph Nodes | 2 | 2017 | 3474 | 0.110 |
Why?
|
Pathology, Surgical | 1 | 2014 | 151 | 0.110 |
Why?
|
Earache | 1 | 2013 | 14 | 0.110 |
Why?
|
Mouth Diseases | 1 | 2015 | 238 | 0.110 |
Why?
|
Aspergillosis | 1 | 2015 | 243 | 0.110 |
Why?
|
Orbital Diseases | 1 | 2015 | 178 | 0.110 |
Why?
|
Hypocalcemia | 1 | 2014 | 199 | 0.110 |
Why?
|
Hypothyroidism | 3 | 2010 | 665 | 0.110 |
Why?
|
Adenoma, Pleomorphic | 1 | 2013 | 75 | 0.110 |
Why?
|
RNA | 2 | 2022 | 2716 | 0.110 |
Why?
|
Pharyngitis | 1 | 2014 | 219 | 0.110 |
Why?
|
Fatal Outcome | 2 | 2015 | 1828 | 0.100 |
Why?
|
Valine | 1 | 2014 | 408 | 0.100 |
Why?
|
Dopamine beta-Hydroxylase | 1 | 2012 | 74 | 0.100 |
Why?
|
Gene Dosage | 2 | 2015 | 1218 | 0.100 |
Why?
|
Retinoblastoma | 1 | 2015 | 317 | 0.100 |
Why?
|
Jaw Cysts | 1 | 2012 | 8 | 0.100 |
Why?
|
Pruritus | 1 | 2015 | 377 | 0.100 |
Why?
|
Leptin | 2 | 2015 | 1591 | 0.100 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 928 | 0.100 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2015 | 323 | 0.100 |
Why?
|
Remote Consultation | 1 | 2014 | 233 | 0.100 |
Why?
|
Choline O-Acetyltransferase | 1 | 2012 | 155 | 0.100 |
Why?
|
Paranasal Sinus Diseases | 1 | 2013 | 121 | 0.100 |
Why?
|
Temporomandibular Joint Disorders | 1 | 2015 | 220 | 0.100 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2012 | 61 | 0.100 |
Why?
|
Hearing Loss, Conductive | 1 | 2013 | 159 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1764 | 0.100 |
Why?
|
Terminology as Topic | 2 | 2016 | 1533 | 0.100 |
Why?
|
Esthesioneuroblastoma, Olfactory | 1 | 2012 | 58 | 0.100 |
Why?
|
Thyroglossal Cyst | 1 | 2011 | 31 | 0.100 |
Why?
|
Biopsy, Needle | 2 | 2014 | 1627 | 0.100 |
Why?
|
src-Family Kinases | 1 | 2014 | 535 | 0.100 |
Why?
|
Laser Therapy | 2 | 2015 | 1082 | 0.100 |
Why?
|
Jaw Neoplasms | 1 | 2012 | 70 | 0.100 |
Why?
|
SKP Cullin F-Box Protein Ligases | 1 | 2012 | 175 | 0.100 |
Why?
|
Tonsillitis | 1 | 2011 | 28 | 0.100 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2011 | 95 | 0.090 |
Why?
|
Metaplasia | 3 | 2021 | 321 | 0.090 |
Why?
|
Brain Edema | 1 | 2015 | 602 | 0.090 |
Why?
|
Lymphatic Diseases | 1 | 2013 | 319 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 6 | 2021 | 20499 | 0.090 |
Why?
|
Mouth Floor | 1 | 2011 | 38 | 0.090 |
Why?
|
Tongue Diseases | 1 | 2011 | 68 | 0.090 |
Why?
|
Dietary Supplements | 1 | 2024 | 3388 | 0.090 |
Why?
|
Craniotomy | 1 | 2015 | 741 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 2016 | 4491 | 0.090 |
Why?
|
Radionuclide Imaging | 1 | 2015 | 1976 | 0.090 |
Why?
|
TRPP Cation Channels | 1 | 2011 | 177 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2293 | 0.090 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2634 | 0.090 |
Why?
|
Disease Progression | 2 | 2020 | 13464 | 0.090 |
Why?
|
Orthostatic Intolerance | 1 | 2010 | 22 | 0.090 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2010 | 101 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2014 | 726 | 0.090 |
Why?
|
Carcinoma in Situ | 1 | 2016 | 793 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2015 | 3774 | 0.090 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2717 | 0.090 |
Why?
|
Mucous Membrane | 1 | 2013 | 657 | 0.090 |
Why?
|
Mouth Neoplasms | 2 | 2015 | 593 | 0.090 |
Why?
|
Antigens, CD1 | 1 | 2012 | 439 | 0.090 |
Why?
|
Nasal Cavity | 1 | 2012 | 304 | 0.090 |
Why?
|
Postural Orthostatic Tachycardia Syndrome | 1 | 2010 | 51 | 0.080 |
Why?
|
Mass Spectrometry | 2 | 2014 | 2189 | 0.080 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 2010 | 180 | 0.080 |
Why?
|
Framycetin | 1 | 2009 | 7 | 0.080 |
Why?
|
Disease Models, Animal | 10 | 2023 | 18123 | 0.080 |
Why?
|
Diagnostic Errors | 2 | 2016 | 1263 | 0.080 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 664 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 544 | 0.080 |
Why?
|
Failure to Thrive | 1 | 2010 | 140 | 0.080 |
Why?
|
Airway Obstruction | 1 | 2014 | 661 | 0.080 |
Why?
|
Interleukin-1 | 3 | 1999 | 1249 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2019 | 3443 | 0.080 |
Why?
|
Spine | 2 | 2020 | 1111 | 0.080 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14638 | 0.080 |
Why?
|
Oncogene Protein v-akt | 1 | 2009 | 129 | 0.080 |
Why?
|
Muscle, Skeletal | 1 | 2024 | 4902 | 0.080 |
Why?
|
Benzodiazepines | 1 | 2015 | 1130 | 0.080 |
Why?
|
Trans-Activators | 3 | 2022 | 2859 | 0.080 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2009 | 81 | 0.080 |
Why?
|
Glutamic Acid | 1 | 2014 | 1167 | 0.080 |
Why?
|
Struma Ovarii | 1 | 2008 | 10 | 0.080 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39018 | 0.080 |
Why?
|
RNA, Viral | 1 | 2017 | 2837 | 0.080 |
Why?
|
Mitochondria | 2 | 2019 | 3584 | 0.080 |
Why?
|
Macrophages | 1 | 2023 | 5736 | 0.080 |
Why?
|
Vision Disorders | 1 | 2015 | 1084 | 0.080 |
Why?
|
Reproducibility of Results | 7 | 2023 | 20039 | 0.080 |
Why?
|
Treatment Outcome | 10 | 2021 | 64242 | 0.080 |
Why?
|
Eosinophils | 1 | 2013 | 947 | 0.080 |
Why?
|
Endoscopy | 2 | 2015 | 1832 | 0.080 |
Why?
|
Carcinoma, Basal Cell | 1 | 2013 | 559 | 0.080 |
Why?
|
Gene Expression Regulation | 2 | 2003 | 11893 | 0.080 |
Why?
|
Combined Modality Therapy | 4 | 2015 | 8515 | 0.070 |
Why?
|
ras Proteins | 2 | 2010 | 1050 | 0.070 |
Why?
|
Hematoma | 1 | 2013 | 768 | 0.070 |
Why?
|
RNA, Messenger | 8 | 2019 | 12761 | 0.070 |
Why?
|
Pyrimidines | 1 | 2020 | 3005 | 0.070 |
Why?
|
Epithelial Cells | 3 | 2016 | 3665 | 0.070 |
Why?
|
Thyroxine | 4 | 2008 | 667 | 0.070 |
Why?
|
Mice, SCID | 4 | 2015 | 2625 | 0.070 |
Why?
|
Preoperative Period | 2 | 2021 | 549 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4313 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3754 | 0.070 |
Why?
|
Cell Movement | 3 | 2020 | 5201 | 0.070 |
Why?
|
Dizziness | 1 | 2010 | 257 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2019 | 8505 | 0.070 |
Why?
|
Consensus | 3 | 2023 | 3098 | 0.070 |
Why?
|
Laryngoscopy | 3 | 2024 | 705 | 0.070 |
Why?
|
Autonomic Nervous System | 1 | 2012 | 697 | 0.070 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2009 | 123 | 0.070 |
Why?
|
Endometrial Neoplasms | 1 | 2016 | 1356 | 0.070 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2016 | 2419 | 0.070 |
Why?
|
Polymerase Chain Reaction | 4 | 2017 | 6069 | 0.070 |
Why?
|
Signal Transduction | 7 | 2020 | 23342 | 0.070 |
Why?
|
Cervical Vertebrae | 1 | 2013 | 977 | 0.070 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1878 | 0.070 |
Why?
|
Heart Rate | 3 | 2010 | 4166 | 0.070 |
Why?
|
Fasciitis, Necrotizing | 1 | 2007 | 79 | 0.070 |
Why?
|
Cysts | 1 | 2012 | 681 | 0.070 |
Why?
|
Quinazolines | 1 | 2013 | 1371 | 0.070 |
Why?
|
Tumor Burden | 3 | 2017 | 1887 | 0.070 |
Why?
|
Child, Preschool | 9 | 2020 | 42044 | 0.070 |
Why?
|
Postoperative Complications | 3 | 2019 | 15532 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3167 | 0.070 |
Why?
|
Fetus | 1 | 2013 | 1860 | 0.070 |
Why?
|
Hypercalcemia | 1 | 2008 | 422 | 0.060 |
Why?
|
Mice, Knockout | 6 | 2020 | 14354 | 0.060 |
Why?
|
Klebsiella Infections | 1 | 2007 | 147 | 0.060 |
Why?
|
Genetic Variation | 2 | 2019 | 6549 | 0.060 |
Why?
|
Blotting, Western | 2 | 2015 | 5031 | 0.060 |
Why?
|
Intraoperative Period | 2 | 2021 | 511 | 0.060 |
Why?
|
Cytokines | 2 | 2022 | 7339 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2018 | 8945 | 0.060 |
Why?
|
Forkhead Transcription Factors | 1 | 2012 | 1611 | 0.060 |
Why?
|
Hernia, Diaphragmatic | 1 | 2006 | 246 | 0.060 |
Why?
|
Fever | 1 | 2013 | 1617 | 0.060 |
Why?
|
Klebsiella pneumoniae | 1 | 2007 | 254 | 0.060 |
Why?
|
Observer Variation | 3 | 2017 | 2599 | 0.060 |
Why?
|
Radiography | 3 | 2013 | 6957 | 0.060 |
Why?
|
Headache | 1 | 2013 | 1249 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5348 | 0.060 |
Why?
|
Lymph Node Excision | 1 | 2010 | 1278 | 0.060 |
Why?
|
Paraffin Embedding | 2 | 2017 | 302 | 0.060 |
Why?
|
Mesenchymoma | 1 | 2024 | 49 | 0.060 |
Why?
|
Piperidines | 1 | 2013 | 1639 | 0.060 |
Why?
|
Wound Healing | 4 | 2012 | 2781 | 0.060 |
Why?
|
Workflow | 2 | 2022 | 850 | 0.060 |
Why?
|
Polysaccharides, Bacterial | 1 | 2007 | 574 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6151 | 0.060 |
Why?
|
Pyrroles | 1 | 2010 | 1127 | 0.060 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2024 | 192 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2020 | 1824 | 0.060 |
Why?
|
Lipid Peroxides | 1 | 2023 | 74 | 0.060 |
Why?
|
Pleural Neoplasms | 1 | 2008 | 609 | 0.060 |
Why?
|
Child | 10 | 2015 | 79787 | 0.060 |
Why?
|
Feces | 1 | 2010 | 1457 | 0.060 |
Why?
|
Thyrotropin, beta Subunit | 1 | 2003 | 4 | 0.050 |
Why?
|
Arthritis, Infectious | 1 | 2007 | 345 | 0.050 |
Why?
|
Tropomyosin | 1 | 2023 | 104 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2024 | 256 | 0.050 |
Why?
|
Delirium | 1 | 2015 | 1663 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2024 | 211 | 0.050 |
Why?
|
Lymphoma, B-Cell | 1 | 2010 | 936 | 0.050 |
Why?
|
Fermentation | 1 | 2023 | 146 | 0.050 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2009 | 615 | 0.050 |
Why?
|
Rete Testis | 1 | 2022 | 10 | 0.050 |
Why?
|
Skin Neoplasms | 2 | 2013 | 5799 | 0.050 |
Why?
|
Prolactin | 1 | 2004 | 621 | 0.050 |
Why?
|
Nephrectomy | 2 | 2021 | 934 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2021 | 6469 | 0.050 |
Why?
|
Hyperthyroxinemia | 1 | 2001 | 3 | 0.050 |
Why?
|
Neck Dissection | 2 | 2017 | 201 | 0.050 |
Why?
|
Mesothelioma | 1 | 2008 | 807 | 0.050 |
Why?
|
Gene Deletion | 1 | 2010 | 2666 | 0.050 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2023 | 430 | 0.050 |
Why?
|
Colon | 1 | 2010 | 1788 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6457 | 0.050 |
Why?
|
Congenital Hypothyroidism | 1 | 2001 | 40 | 0.050 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2022 | 189 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 3338 | 0.050 |
Why?
|
Thrombospondin 1 | 1 | 2023 | 257 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5272 | 0.050 |
Why?
|
Antipsychotic Agents | 1 | 2015 | 3060 | 0.050 |
Why?
|
Glossectomy | 1 | 2021 | 60 | 0.050 |
Why?
|
Infant | 4 | 2015 | 36043 | 0.050 |
Why?
|
Hormones | 2 | 2022 | 867 | 0.050 |
Why?
|
Calcinosis | 1 | 2010 | 1467 | 0.050 |
Why?
|
Antigens, Bacterial | 1 | 2007 | 1155 | 0.050 |
Why?
|
United States | 4 | 2023 | 71907 | 0.050 |
Why?
|
Dendritic Cells | 1 | 2012 | 2723 | 0.050 |
Why?
|
Neural Pathways | 1 | 2012 | 3040 | 0.050 |
Why?
|
Time Factors | 3 | 2020 | 39815 | 0.050 |
Why?
|
Lipids | 1 | 2012 | 3326 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2011 | 2800 | 0.050 |
Why?
|
Fluorescence | 1 | 2023 | 749 | 0.050 |
Why?
|
Response Elements | 1 | 2002 | 308 | 0.050 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2013 | 2198 | 0.050 |
Why?
|
Protein Isoforms | 2 | 2003 | 1694 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2021 | 26173 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2825 | 0.050 |
Why?
|
Hydrocortisone | 1 | 2008 | 1802 | 0.040 |
Why?
|
Ribonuclease III | 1 | 2022 | 279 | 0.040 |
Why?
|
Liver | 4 | 2005 | 7503 | 0.040 |
Why?
|
Recurrence | 1 | 2013 | 8426 | 0.040 |
Why?
|
Medical Oncology | 2 | 2022 | 2308 | 0.040 |
Why?
|
Pregnancy | 2 | 2021 | 29720 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3524 | 0.040 |
Why?
|
Xenopus laevis | 1 | 2004 | 965 | 0.040 |
Why?
|
Cleft Palate | 1 | 2006 | 587 | 0.040 |
Why?
|
Phosphotransferases | 1 | 2021 | 302 | 0.040 |
Why?
|
Arrhythmias, Cardiac | 1 | 2010 | 2248 | 0.040 |
Why?
|
Bacteremia | 1 | 2007 | 978 | 0.040 |
Why?
|
Cohort Studies | 6 | 2020 | 41198 | 0.040 |
Why?
|
Rabbits | 5 | 2015 | 4771 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2003 | 1751 | 0.040 |
Why?
|
DEAD-box RNA Helicases | 1 | 2022 | 383 | 0.040 |
Why?
|
Kazakhstan | 1 | 2019 | 19 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2015 | 6808 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2014 | 2859 | 0.040 |
Why?
|
Hypopharynx | 1 | 2019 | 53 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2022 | 622 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2014 | 2443 | 0.040 |
Why?
|
Albumins | 1 | 2001 | 575 | 0.040 |
Why?
|
Fluoroacetates | 1 | 2018 | 14 | 0.040 |
Why?
|
Hyperplasia | 1 | 2022 | 1153 | 0.040 |
Why?
|
Point Mutation | 2 | 2005 | 1594 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 3800 | 0.040 |
Why?
|
Glottis | 1 | 2020 | 214 | 0.040 |
Why?
|
Thyroglobulin | 2 | 2009 | 111 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2020 | 326 | 0.040 |
Why?
|
Haploidy | 1 | 2018 | 133 | 0.040 |
Why?
|
Medical Illustration | 1 | 2019 | 135 | 0.040 |
Why?
|
Transcription, Genetic | 2 | 2009 | 7590 | 0.040 |
Why?
|
Gene Expression | 2 | 2002 | 7584 | 0.040 |
Why?
|
Sphingosine | 1 | 2020 | 308 | 0.040 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2011 | 1851 | 0.040 |
Why?
|
Corneal Stroma | 1 | 1999 | 171 | 0.040 |
Why?
|
Albuminuria | 1 | 2001 | 650 | 0.040 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2019 | 239 | 0.040 |
Why?
|
Lysophospholipids | 1 | 2020 | 338 | 0.040 |
Why?
|
DNA Probes, HPV | 1 | 2017 | 21 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13267 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2020 | 628 | 0.040 |
Why?
|
Head | 1 | 2023 | 921 | 0.040 |
Why?
|
DNA-Binding Proteins | 3 | 2022 | 9574 | 0.040 |
Why?
|
RNA Probes | 1 | 2017 | 111 | 0.040 |
Why?
|
Fixatives | 1 | 2017 | 91 | 0.040 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2017 | 105 | 0.040 |
Why?
|
Japan | 1 | 2021 | 1364 | 0.030 |
Why?
|
MAP Kinase Signaling System | 2 | 2014 | 1477 | 0.030 |
Why?
|
Gelatinases | 1 | 1996 | 88 | 0.030 |
Why?
|
Apoptosis | 3 | 2020 | 9469 | 0.030 |
Why?
|
Automation, Laboratory | 1 | 2017 | 103 | 0.030 |
Why?
|
Multigene Family | 1 | 1999 | 1076 | 0.030 |
Why?
|
Choline | 1 | 2018 | 513 | 0.030 |
Why?
|
Kinetics | 2 | 2022 | 6371 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2019 | 5195 | 0.030 |
Why?
|
Gender Identity | 1 | 2022 | 757 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2004 | 1170 | 0.030 |
Why?
|
Prostatic Neoplasms | 2 | 2009 | 11075 | 0.030 |
Why?
|
Prospective Studies | 4 | 2023 | 54108 | 0.030 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 1996 | 138 | 0.030 |
Why?
|
Collagen | 1 | 2004 | 2634 | 0.030 |
Why?
|
Tretinoin | 1 | 1999 | 519 | 0.030 |
Why?
|
Heterozygote | 2 | 2019 | 2797 | 0.030 |
Why?
|
Respiratory Sounds | 1 | 2020 | 697 | 0.030 |
Why?
|
Salivary Gland Diseases | 1 | 2015 | 37 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2017 | 241 | 0.030 |
Why?
|
Keratin-13 | 1 | 2015 | 11 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2023 | 1897 | 0.030 |
Why?
|
Chemokines, CXC | 1 | 1997 | 421 | 0.030 |
Why?
|
Transfection | 2 | 2015 | 5779 | 0.030 |
Why?
|
Corneal Ulcer | 1 | 1996 | 128 | 0.030 |
Why?
|
Formaldehyde | 1 | 2017 | 358 | 0.030 |
Why?
|
Mucorales | 1 | 2015 | 35 | 0.030 |
Why?
|
Aspergillus | 1 | 2015 | 92 | 0.030 |
Why?
|
Radiography, Panoramic | 1 | 2015 | 118 | 0.030 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2016 | 763 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2015 | 127 | 0.030 |
Why?
|
Temporal Muscle | 1 | 2015 | 36 | 0.030 |
Why?
|
Cornea | 3 | 1997 | 1326 | 0.030 |
Why?
|
Cell Nucleolus | 1 | 2015 | 156 | 0.030 |
Why?
|
Vitamin D | 1 | 2008 | 3283 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 1 | 2015 | 609 | 0.030 |
Why?
|
Surgicenters | 1 | 2014 | 45 | 0.030 |
Why?
|
Allergens | 1 | 2022 | 1402 | 0.030 |
Why?
|
Homozygote | 2 | 2014 | 1788 | 0.030 |
Why?
|
Oncogenes | 1 | 2020 | 1222 | 0.030 |
Why?
|
Mandibular Condyle | 1 | 2015 | 115 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1622 | 0.030 |
Why?
|
Hyperbaric Oxygenation | 1 | 2015 | 165 | 0.030 |
Why?
|
Fascia | 1 | 2015 | 140 | 0.030 |
Why?
|
Poland | 1 | 2014 | 196 | 0.030 |
Why?
|
Eye Neoplasms | 1 | 2016 | 306 | 0.030 |
Why?
|
Amino Acid Substitution | 2 | 2014 | 1734 | 0.030 |
Why?
|
Tissue Embedding | 1 | 2013 | 42 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2018 | 9519 | 0.030 |
Why?
|
Cells, Cultured | 5 | 2012 | 18941 | 0.030 |
Why?
|
Immunoenzyme Techniques | 2 | 2012 | 1704 | 0.030 |
Why?
|
Immunocompetence | 1 | 2014 | 138 | 0.030 |
Why?
|
RNA Interference | 2 | 2012 | 2836 | 0.030 |
Why?
|
Tracheotomy | 1 | 2014 | 167 | 0.030 |
Why?
|
Digestive System Neoplasms | 1 | 2013 | 81 | 0.030 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2020 | 940 | 0.030 |
Why?
|
Myocardium | 2 | 2003 | 4690 | 0.030 |
Why?
|
Telomerase | 1 | 2018 | 745 | 0.030 |
Why?
|
Hypoparathyroidism | 1 | 2014 | 136 | 0.030 |
Why?
|
Laparotomy | 1 | 2015 | 454 | 0.030 |
Why?
|
Spinal Puncture | 1 | 2015 | 281 | 0.030 |
Why?
|
Mouth | 1 | 2015 | 380 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2015 | 630 | 0.030 |
Why?
|
Mouth Mucosa | 1 | 2015 | 426 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2015 | 653 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12685 | 0.030 |
Why?
|
Fibroblasts | 3 | 1999 | 4087 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2006 | 4047 | 0.030 |
Why?
|
Synovial Fluid | 1 | 2015 | 395 | 0.030 |
Why?
|
Debridement | 1 | 2015 | 492 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2020 | 6128 | 0.030 |
Why?
|
Arthroplasty | 1 | 2015 | 313 | 0.030 |
Why?
|
Palate, Hard | 1 | 2012 | 58 | 0.030 |
Why?
|
Rats | 3 | 2018 | 23681 | 0.030 |
Why?
|
Weight Gain | 1 | 2002 | 2345 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4845 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2018 | 1846 | 0.020 |
Why?
|
Vacuoles | 1 | 2012 | 228 | 0.020 |
Why?
|
Creatine Kinase | 2 | 2005 | 686 | 0.020 |
Why?
|
Synovial Membrane | 1 | 2015 | 524 | 0.020 |
Why?
|
RNA, Small Interfering | 2 | 2012 | 3432 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1155 | 0.020 |
Why?
|
Dexamethasone | 1 | 1999 | 1927 | 0.020 |
Why?
|
Phosphorylation | 2 | 2014 | 8298 | 0.020 |
Why?
|
Preoperative Care | 2 | 2012 | 2246 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2002 | 2868 | 0.020 |
Why?
|
Ovarian Neoplasms | 1 | 2008 | 4873 | 0.020 |
Why?
|
Frozen Sections | 1 | 2012 | 153 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 1999 | 1957 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2014 | 640 | 0.020 |
Why?
|
Actins | 2 | 2015 | 2049 | 0.020 |
Why?
|
Protein Precursors | 1 | 2015 | 1133 | 0.020 |
Why?
|
Mastoid | 1 | 2011 | 98 | 0.020 |
Why?
|
Carcinoembryonic Antigen | 1 | 2011 | 337 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2020 | 2824 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2011 | 384 | 0.020 |
Why?
|
Antifungal Agents | 1 | 2015 | 749 | 0.020 |
Why?
|
Pedigree | 3 | 2005 | 4578 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2013 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1894 | 0.020 |
Why?
|
Pyrazoles | 1 | 2020 | 1994 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2018 | 2012 | 0.020 |
Why?
|
Boston | 2 | 2016 | 9297 | 0.020 |
Why?
|
Epithelium | 1 | 2014 | 1605 | 0.020 |
Why?
|
Microscopy | 1 | 2014 | 883 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 473 | 0.020 |
Why?
|
Heart | 1 | 2002 | 4382 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 477 | 0.020 |
Why?
|
Neomycin | 1 | 2009 | 93 | 0.020 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2011 | 243 | 0.020 |
Why?
|
Metyrapone | 1 | 2008 | 22 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 2016 | 977 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3299 | 0.020 |
Why?
|
Mitotane | 1 | 2008 | 20 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7199 | 0.020 |
Why?
|
Immunoblotting | 1 | 2012 | 1647 | 0.020 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2009 | 189 | 0.020 |
Why?
|
Isoenzymes | 1 | 2013 | 1686 | 0.020 |
Why?
|
Dactinomycin | 1 | 2009 | 304 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3816 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2012 | 896 | 0.020 |
Why?
|
Pyridines | 1 | 2020 | 2864 | 0.020 |
Why?
|
China | 1 | 2014 | 2336 | 0.020 |
Why?
|
Blotting, Northern | 2 | 2002 | 1543 | 0.020 |
Why?
|
Gene Amplification | 1 | 2012 | 1086 | 0.020 |
Why?
|
Cell Line | 2 | 2012 | 15594 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2012 | 764 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2012 | 2753 | 0.020 |
Why?
|
Arthroscopy | 1 | 2015 | 960 | 0.020 |
Why?
|
Emergencies | 1 | 2014 | 1209 | 0.020 |
Why?
|
Reference Values | 1 | 2015 | 4918 | 0.020 |
Why?
|
Viral Proteins | 1 | 2015 | 1803 | 0.020 |
Why?
|
Cell Differentiation | 3 | 2014 | 11470 | 0.020 |
Why?
|
Lymphocytes | 1 | 2015 | 2611 | 0.020 |
Why?
|
Radioimmunoassay | 2 | 1999 | 866 | 0.020 |
Why?
|
Ubiquitination | 1 | 2012 | 1008 | 0.020 |
Why?
|
Tight Junctions | 1 | 2010 | 317 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2002 | 22008 | 0.020 |
Why?
|
Random Allocation | 1 | 2011 | 2387 | 0.020 |
Why?
|
Swine | 2 | 2013 | 5892 | 0.020 |
Why?
|
Osteoarthritis | 1 | 2015 | 1056 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8551 | 0.020 |
Why?
|
Cambodia | 1 | 2007 | 186 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2008 | 617 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4235 | 0.020 |
Why?
|
Bacterial Capsules | 1 | 2007 | 242 | 0.020 |
Why?
|
Surgical Flaps | 1 | 2015 | 1669 | 0.020 |
Why?
|
HeLa Cells | 1 | 2012 | 3095 | 0.020 |
Why?
|
Microsurgery | 1 | 2011 | 796 | 0.020 |
Why?
|
Palate, Soft | 1 | 2006 | 100 | 0.020 |
Why?
|
Cell Survival | 1 | 2015 | 5782 | 0.020 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 2005 | 139 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4641 | 0.020 |
Why?
|
Reoperation | 1 | 2015 | 4279 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2009 | 675 | 0.020 |
Why?
|
Metamorphosis, Biological | 1 | 2004 | 37 | 0.020 |
Why?
|
Cholesterol | 2 | 2005 | 2900 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5325 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2014 | 2565 | 0.010 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2004 | 102 | 0.010 |
Why?
|
Brain | 1 | 2011 | 26950 | 0.010 |
Why?
|
Tail | 1 | 2004 | 92 | 0.010 |
Why?
|
MicroRNAs | 1 | 2020 | 3782 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2015 | 3480 | 0.010 |
Why?
|
Fetal Death | 1 | 2006 | 434 | 0.010 |
Why?
|
Laparoscopy | 1 | 2015 | 2032 | 0.010 |
Why?
|
Down-Regulation | 1 | 2011 | 2903 | 0.010 |
Why?
|
Craniofacial Abnormalities | 1 | 2006 | 315 | 0.010 |
Why?
|
Cell Cycle | 1 | 2011 | 2930 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2009 | 1240 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4258 | 0.010 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2005 | 546 | 0.010 |
Why?
|
Risk Assessment | 2 | 2016 | 23819 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2009 | 1753 | 0.010 |
Why?
|
Larva | 1 | 2004 | 507 | 0.010 |
Why?
|
Abdomen | 1 | 2009 | 1125 | 0.010 |
Why?
|
Feedback | 2 | 1997 | 791 | 0.010 |
Why?
|
Ferritins | 1 | 2005 | 597 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 1995 | 2475 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10718 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2012 | 2552 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9460 | 0.010 |
Why?
|
Linear Models | 1 | 2011 | 5857 | 0.010 |
Why?
|
Skin | 1 | 1995 | 4464 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10075 | 0.010 |
Why?
|
Travel | 1 | 2007 | 783 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7366 | 0.010 |
Why?
|
Zebrafish | 1 | 2012 | 2992 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12400 | 0.010 |
Why?
|
Coculture Techniques | 1 | 2004 | 1339 | 0.010 |
Why?
|
Software | 1 | 2014 | 4416 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 13447 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9312 | 0.010 |
Why?
|
Up-Regulation | 1 | 2009 | 4113 | 0.010 |
Why?
|
Growth Hormone | 1 | 2002 | 568 | 0.010 |
Why?
|
Pituitary Gland, Anterior | 1 | 1999 | 142 | 0.010 |
Why?
|
Syndrome | 1 | 2006 | 3261 | 0.010 |
Why?
|
Epilepsy | 1 | 2015 | 3270 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17617 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2895 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2010 | 2809 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22024 | 0.010 |
Why?
|
Mammals | 1 | 2004 | 1132 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 2002 | 866 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 2006 | 1414 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15782 | 0.010 |
Why?
|
Autocrine Communication | 1 | 1999 | 169 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12047 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2011 | 2741 | 0.010 |
Why?
|
Risk Factors | 2 | 2015 | 73716 | 0.010 |
Why?
|
Chemokine CXCL5 | 1 | 1997 | 28 | 0.010 |
Why?
|
Contrast Media | 1 | 2011 | 5297 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13222 | 0.010 |
Why?
|
Genome, Human | 1 | 2010 | 4414 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 21217 | 0.010 |
Why?
|
Cytochalasin B | 1 | 1995 | 74 | 0.010 |
Why?
|
Basement Membrane | 1 | 1996 | 348 | 0.010 |
Why?
|
Haplotypes | 1 | 2002 | 2764 | 0.010 |
Why?
|
Eye Injuries, Penetrating | 1 | 1997 | 121 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2000 | 2381 | 0.010 |
Why?
|
Glioblastoma | 1 | 2010 | 3480 | 0.010 |
Why?
|
Metalloendopeptidases | 1 | 1996 | 393 | 0.010 |
Why?
|
Trypsin | 1 | 1995 | 496 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1995 | 818 | 0.010 |
Why?
|
Genetic Markers | 1 | 2000 | 2608 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11709 | 0.010 |
Why?
|
Interleukin-8 | 1 | 1997 | 696 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2021 | 20999 | 0.010 |
Why?
|
Drug Resistance | 1 | 1999 | 1593 | 0.010 |
Why?
|
Obesity | 1 | 2015 | 12869 | 0.010 |
Why?
|
Granuloma | 1 | 1995 | 327 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4602 | 0.010 |
Why?
|
NF-kappa B | 1 | 1999 | 2472 | 0.010 |
Why?
|
Echocardiography | 1 | 2002 | 4962 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1996 | 8145 | 0.000 |
Why?
|
Models, Genetic | 1 | 1995 | 3441 | 0.000 |
Why?
|